Target intelligence / Profile preview

Solute carrier family 2 member 11 (SLC2A11)

Target
SLC2A11
Molecular classification
Transporter, Glucose transporter (facilitative), Solute carrier family protein
01

Overview

Solute carrier family 2 member 11 (SLC2A11; GLUT11) is a facilitative glucose transporter protein encoded by the SLC2A11 gene. It is a member of the extended GLUT family and mediates the transport of sugars like glucose and fructose across cell membranes by facilitative diffusion. SLC2A11 is specifically expressed in heart and skeletal muscle, suggesting a tissue-restricted physiological role. The protein possesses 12 membrane-spanning domains typical of GLUT transporters. Unlike GLUT4, GLUT11’s transport activity is markedly inhibited by fructose. Its closest known paralog is GLUT5 (SLC2A5)[1][3][4]. There is currently no evidence of SLC2A11 being a major therapeutic drug target or being used as a clinical biomarker. Some disease associations are listed in genetic databases, but functional evidence remains limited. Caution is required when reviewing literature, as SLC2A11 has sometimes been erroneously referred to as GLUT10, which appropriately refers to SLC2A10[4].

Other names
SLC2A11GLUT11Solute carrier family 2, facilitated glucose transporter member 11Glucose transporter type 11Facilitative glucose transporter GLUT11Glucose transporter-like protein XIGTR11
02

Mechanism of action

Not applicable; no known drugs directly target SLC2A11[3][4].

03

Biological functions

Transport of glucoseTransport of fructoseSugar transmembrane transporter activity[1][3][4]Facilitative diffusion of sugars across plasma membrane
04

Disease associations

Fructosuria, essential (association only, based on gene-disease databases)[3]Hyperphenylalaninemia, BH4-deficient (association only)[3]
05

Safety considerations

None notable; target biology and tissue restriction, mainly muscle, may lower risk of widespread systemic toxicity[1].No therapeutic drugs described; thus, safety not established.
06

Interacting drugs

None known or referenced in current databases[3][4].
07

Biomarkers

None clearly established for patient selection or monitoring[3][4].

Beyond the preview

Go deeper on Solute carrier family 2 member 11 (SLC2A11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 2 member 11 (SLC2A11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call